Skip to main content
Clinical Trials/IRCT2015012420740N2
IRCT2015012420740N2
Completed
未知

Comparison of combined intralesional injection of glucantime and interferon gamma with intralesional glucantime alone in the treatment of cutaneous leishmaniasis

Mashhad University of Medical Sciences, Vice Chancellor for Research0 sites90 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Cutaneous Leishmaniasis.
Sponsor
Mashhad University of Medical Sciences, Vice Chancellor for Research
Enrollment
90
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Mashhad University of Medical Sciences, Vice Chancellor for Research

Eligibility Criteria

Inclusion Criteria

  • Inclusion criterias: Positive smear or biopsy of the lesion in terms of Amastigotes; Not sensitivity to glucantime; The patient who has indications of topical treatment based on state protocol; Less than one year past from onset of the illness; No treatment is received in at least 2 months; Not pregnant and not lactating; The patient is willing to participate in the study. exclusion criterias: No have regular visit; Secondary infection of the lesion based on clinical features and judging therapist; Use of other medications during the study.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials